Lundbeck research projects secure funding from The Michael J. Fox Foundation
14 October 2013 | By H. Lundbeck A/S
The Michael J. Fox Foundation has donated 5.5 million kroner to two Danish research projects in Parkinson's disease...
List view / Grid view
14 October 2013 | By H. Lundbeck A/S
The Michael J. Fox Foundation has donated 5.5 million kroner to two Danish research projects in Parkinson's disease...
20 March 2013 | By H. Lundbeck A/S
Results add to evidence for Azilect as an effective and well-tolerated treatment option at different stages of the progression of PD...
18 June 2012 | By Abbott
Results from five abstracts announced...
17 April 2012 | By Abbott
Statistically significant improvements...
9 June 2011 | By Abbott
After 12 weeks of treatment with levodopa-carbidopa intestinal gel patients reported improvement in motor symptoms...
27 April 2011 | By Eli Lilly & Company
Collaboration combines companies' expertise in neuroscience and targeted drug delivery...
17 January 2011 | By Andrew Lloyd & Associates
Agreement covers metabotropic glutamate receptor 4 (mGluR4) Positive Allosteric Modulator (PAM) drugs targeting Parkinson's disease...
20 December 2010 | By M:Communications
Proximagen, has signed an exclusive agreement with GSK to acquire the global rights to two drug development programmes...